April 7, 1:00 p.m.
Fireside Chat with Max Wallace and Don Lo
April 7th ; 1:00 PM
Okey Patteson Auditorium
Max Wallace and Don Lo are joining us on April 7th for a free ranging Fireside Chat about their experiences launching successful life science companies from academic institutions, work they have done in commercializing breakthrough discoveries, and research and their views on the role academia plays in bringing cutting edge treatments to patients.
Max is CEO of Accelerate Brain Cancer Cure, and was previously: CEO of TheraLogics (cancer therapeutics), Founder and President of Trimeris (HIV Therapeutics), Founder Cogent Neuroscience, Sphinx Pharmaceuticals, and SARCO. He is an active board member of tissue engineering company, Humacyte – Fast company referenced them as one of the 10 most innovative biotech companies in the US and they recently completed a $150 Million financing.
Don is Director of the Center for Drug Discovery at Duke University and Associate Professor of Neurobiology at Duke Medical Center. He has been engaged in basic science and drug discovery research for neurological diseases for over 25 years. Don was Co-founder and Chief Science Officer of Cogent Neuroscience until 2002 when he returned to Duke to establish Duke’s Center for Drug Discovery.
Come celebrate with the WVU community and special guests on April 7, 4:30 p.m. at the Blanchette Rockefeller Neurosciences Institute as we open the doors to WVU’s new “Health Sciences Innovation Center.”
This is the new home of our life sciences technology transfer team, and includes incubation wet labs for WVU's growing roster of life sciences startups. Tour the labs and meet some of the life sciences startups that are beginning to be incubated at the Health Sciences Innovation Center.
For more information, please contact:
Director Health Sciences Innovation, Entrepreneurship, and Commercialization
2268 Health Sciences South
Brian Boone, M.D., surgical oncologist in the WVU Medicine Department of Surgery and WVU Cancer Institute, performed the state’s first hyperthermic intraperitoneal chemotherapy (HIPEC) infusion. This treatment delivers heated, sterilized chemotherapy to the abdomen as a treatment for cancer that has spread to the lining of the abdominal cavity, or peritoneum.
WVU Medicine Obstetrics and Gynecology has experienced remarkable growth over the last two years. By increasing its team of gynecologic oncologists and adding a nurse practitioner, physician assistant, and genetic counselor, the department has expanded its capability to serve gynecologic cancer patients.
The annual Holiday Celebration for WVU Medicine and Health Sciences employees will kick off on Thurs., Dec. 6, from 2 to 4 p.m. at The Market, located on the ground floor of the Health Sciences Center. The Market will close at 11:30 a.m. for the celebration.